nach oben

World Journal of Urology

Erschienen in:

01.09.2006 | Topic Paper

Transurethral microwave thermotherapy for the treatment of BPH: still a challenger?

verfasst von: T. R. W. Herrmann, A. J. Gross, D. Schultheiss, P. M. Kaufmann, U. Jonas, M. Burchardt

Erschienen in: World Journal of Urology | Ausgabe 4/2006

Einloggen, um Zugang zu erhalten

Abstract

Minimally invasive therapies for treatment of benign prostatic hyperplasia (BPH) compete with the gold standard transurethral resection of the prostate (TURP). Comparisons of efficacy and safety have broadened the knowledge of different treatment modalities. Concerns of quality of life such as unaltered sexual function as well as cost considerations drive the market to develop techniques of lower level invasiveness. Among the competitors the office based transurethral microwave thermotherapy (TUMT) provides the broadest scale of scientific data. Numerous manufacturers sell various modifications of this technology. According to different clinical studies TUMT proved to be an effective, safe, and durable therapy for the treatment of lower urinary tract symptoms (LUTS) secondary to BPH. However, TURP still holds the steadier long-term results and is more effective to reduce obstruction as well as other LUTS.

Verhamme KMC, Dieleman JP, Bleumink GS, et al (2002) Incidence and prevalence of lower urinary tract symptoms suggestive of benign prostatic hyperplasia in primary care—the Triumph project. Eur Urol 42:323–328PubMedCrossRef

Mebust WK, Hotgrewe HL, Cockett ATK, Peters PC (1989) Transurethral prostatectomy: immediate and postoperative complications. A cooperative study of 13 participating institutions evaluating 3,885 patients. J Urol 141:243–247PubMed

Oesterling JE (1995) Benign prostatic hyperplasia. Medical and minimally invasive treatment options. N Engl J Med 332:99–109PubMedCrossRef

Lepor H, Oesterling JE, Wasson JH (1996) BPH management: minimal to maximal. Patient Care 29:18–35

Jepsen JV, Bruskewitz RC (1998) Recent developments in the surgical management of benign prostatic hyperplasia. Urology 51(Suppl. 4A):23–31PubMedCrossRef

Tewari A, Oleska J, Johnson C, Peabody J, Menon M, Kamerer A, Narayan P (1999) Minimally invasive therapy of benign prostatic hypertrophy. Hosp Physician 35(5):29–43, 68

AUA Practice Guidelines Committee: AUA guideline on management of benign prostatic hyperplasia (2003) Chapter 1: diagnosis and treatment recommendations. J Urol 170(2 Pt 1):530–547

Kyprianou N (2003) Doxazosin and terazosin suppress prostate growth by inducing apoptosis: clinical significance. J Urol 169:1520–1525PubMedCrossRef

Bolmsjo M, Wagrell L, Hallin A, Eliasson T, Erlandsson BE, Mattiasson A (1996) The heat is on—but how? A comparison of TUMT devices. Br J Urol 78:564–572PubMed

10.

Brehmer M, Baba S (2000) Transurethral microwave thermotherapy: how does it work? J Endourol 14:611–615PubMedCrossRef

11.

Brehmer M (1997) Morphological changes in prostatic adenomas after transurethral microwave thermotherapy. Br J Urol 80:123–127PubMed

12.

Brehmer M, Svensson I (2000) Heat-induced apoptosis in human prostatic stromal cells. BJU Int 85:535–541PubMedCrossRef

13.

Corvin S, Boesch S, Maneschg C, Radmayr C, Bartsch G, Klocker H (2000) Effect of heat exposure on viability and contractility of cultured prostatic stromal cells. Eur Urol 37(4):499–504PubMedCrossRef

14.

Brehmer M, Hilliges M, Kinn AC (2000) Denervation of periurethral prostatic tissue by transurethral microwave thermotherapy. Scand J Urol Nephrol 34:42–45PubMedCrossRef

15.

Brehmer M, Nilsson BY (2000) Elevation of sensory thresholds in the prostatic urethra after microwave thermotherapy. BJU Int 86:427–431PubMedCrossRef

16.

Huidobro C, Bolmsjo M, Larson T, de la Rosette J, Wagrell L, Schelin S, Gorecki T, Mattiasson A (2004) Evaluation of microwave thermotherapy with histopathology, magnetic resonance imaging and temperature mapping. J Urol 171:672–678PubMedCrossRef

17.

Walmsley K, Kaplan SA (2004) Transurethral microwave thermotherapy for benign prostate hyperplasia: separating truth from marketing hype. J Urol 172(4 Pt 1):1249–1255PubMedCrossRef

18.

Albala DM, Fulmer BR, Turk TM, Koleski F, Andriole G, Davis BE, Eure GR, Kabalin JN, Lingeman JE, Nuzzarello J, Sundaram C (2002) Office-based transurethral microwave thermotherapy using the Thermatrx TMx-2000. J Endourol 16(1):57–61PubMedCrossRef

19.

Wagrell L, Schelin S, Nordling J, Richthoff J, Magnusson B, Schain M, Larson T, Boyle E, Duelund J, Kroyer K, Ageheim H, Mattiasson A (2002) Feedback microwave thermotherapy versus TURP for clinical BPH—a randomized controlled multicenter study. Urology 60:292–299PubMedCrossRef

20.

Laguna MP, Kiemeney LA, Debruyne FM, de la Rosette JJ (2002) Related Articles. Baseline prostate specific antigen does not predict the outcome of high energy transurethral microwave thermotherapy. J Urol 167(4):1727–1730PubMedCrossRef

21.

Huidobro C, Cabezas J, Cote E, Mynderse L, Partin A, Preminger G et al (2003) Results of a new advancement in high temperature cooled thermotherapy (TUMT) for benign prostatic hyperplasia (BPH). J Urol 169(Suppl.):390, abstract 1459

22.

Gravas S, Laguna MP, de la Rosette JJ (2003) Efficacy and safety of intraprostatic temperature-controlled microwave thermotherapy in patients with benign prostatic hyperplasia: results of a prospective, open-label, single-center study with a 1-year follow-up. J Endourol 17:425PubMedCrossRef

23.

Albala DM, Andriole G, Davis BE, Eure GR, Kabalin JN, Lingeman JE (2003) Transurethral microwave thermotherapy (TUMT) using the Thermatrx TMX-2000: durability exhibited in a study comparing TUMT with a sham procedure in patients with benign prostatic hyperplasia (BPH). J Urol 169(Suppl.):465, abstract 1746

24.

Djavan B, Seitz C, Roehrborn CG, Remzi M, Fakhari M, Waldert M (2001) Targeted transurethral microwave thermotherapy versus alpha-blockade in benign prostatic hyperplasia: outcomes at 18 months. Urology 57:66PubMedCrossRef

25.

Kaplan SA, Blute M, Bruskewitz RC, Larson TR, Utz W, Ugarte R et al (2002) Long term efficacy and durability in 345 patients treated with transurethral microwave thermotherapy for benign prostatic hyperplasia: five year results. J Urol 167(Suppl.):297, abstract 1153

26.

D’Ancona FC, Francisca EA, Witjes WP, Welling L, Debruyne FM, De La Rosette JJ (1998) Transurethral resection of the prostate vs high-energy thermotherapy of the prostate in patients with benign prostatic hyperplasia: long-term results. Br J Urol 81:259–264PubMed

27.

Francisca EA, d’Ancona FC, Meuleman EJ, Debruyne FM, de la Rosette JJ (1999) Sexual function following high energy microwave thermotherapy: results of a randomized controlled study comparing transurethral microwave thermotherapy to transurethral prostatic resection. J Urol 161:486–490PubMedCrossRef

28.

Floratos DL, Kiemeney LA, Rossi C, Kortmann BB, Debruyne FM, de la Rosette JJ (2001) Long-term followup of randomized transurethral microwave thermotherapy versus transurethral prostatic resection study. J Urol 165:1533–1538PubMedCrossRef

29.

Selvaggio O, Ditonno P, Battaglia M, Bettocchi C, Saracino A, Palazzo S, et al (2003) Long term results (4 years) of high-energy transurethral microwave. Eur Urol 2:102

30.

Laguna P, van Hest P, Smelov V, Gravas S, Kiemeney B, de la Rosette JJ (2002) Efficacy and durability of the 30 minutes high energy TUMT protocol in 213 patients. J Endourol 15:38, abstract P023

31.

Vesely S, Knutson T, Dicuio M, Damber JE, Dahlstrand C (2005) Transurethral microwave thermotherapy: clinical results after 11 years of use. J Endourol 19:730–733PubMedCrossRef

32.

Ahmed M, Bell T, Lawrence WT, Ward JP, Watson GM (1997) Transurethral microwave thermotherapy (Prostatron version 2.5) compared with transurethral resection of the prostate for the treatment of benign prostatic hyperplasia: a randomized, controlled, parallel study. Br J Urol 79:181–185PubMed

33.

Dahlstrand C, Walden M, Geirsson G, Pettersson S (1995) Transurethral microwave thermotherapy versus transurethral resection for symptomatic benign prostatic obstruction: a prospective randomized study with a 2-year followup. Br J Urol 76:614–618PubMedCrossRef

34.

Dahlstrand C, Walden M, Geirsson G, Sommar S, Pettersson S (1994) Transurethral microwave thermotherapy versus transurethral resection for BPH. Prog Clin Biol Res 386:455–461PubMed

35.

Dahlstrand C, Geirsson G, Fall M, Pettersson S (1993) Transurethral microwave thermotherapy versus transurethral resection for benign prostatic hyperplasia: preliminary results of a randomized study. Eur Urol 23:292–298PubMed

36.

D’Ancona FC, Francisca EA, Witjes WP, Welling L, Debruyne FM, de la Rosette JJ (1997) High energy thermotherapy versus transurethral resection in the treatment of benign prostatic hyperplasia: results of a prospective randomized study with 1 year of followup. J Urol 158:120–125PubMedCrossRef

37.

Francisca EA, d’Ancona FC, Hendriks JC, Kiemeney LA, Debruyne FM, de la Rosette JJ (2000) A randomized study comparing high-energy TUMT to TURP. Quality-of-life results. Eur Urol 38:569–575PubMedCrossRef

38.

Norby B, Nielsen HV, Frimodt-Moller PC (2002) Transurethral interstitial laser coagulation of the prostate and transurethral microwave thermotherapy vs transurethral resection or incision of the prostate: results of a randomized, controlled study in patients with symptomatic benign prostatic hyperplasia. BJU Int 90:853–862PubMedCrossRef

39.

Hoffman RM, MacDonald R, Monga M, Wilt TJ (2004) Transurethral microwave thermotherapy vs transurethral resection for treating benign prostatic hyperplasia: a systematic review. BJU Int 94:1031–1036PubMedCrossRef

40.

Gonzalez RR, Te AE (2003) How do transurethral needle ablation of the prostate and transurethral microwave thermotherapy compare with transurethral prostatectomy? Curr Urol Rep 4:297PubMedCrossRef

41.

De la Blute MJ, Desgrandchamp F (1998) Transurethral thermotherapy using the Prostatron device. World J Urol 16:89CrossRef

42.

Leliefeld HH, Stoevelaar HJ, McDonnell J (2002) Sexual function before and after various treatments for symptomatic benign prostatic hyperplasia. BJU Int 89:208–213PubMedCrossRef

43.

Fowler FJ Jr, Barry MJ (1993) Quality of life assessment for evaluating benign prostatic hyperplasia treatments. An example of using a condition-specific index. Eur Urol 24(Suppl. 1):24–27PubMed

44.

Kassabian VS (2003) Sexual function in patients treated for benign prostatic hyperplasia. Lancet 361:60–62PubMedCrossRef

45.

Hofner K, Gonnermann O, Grunewald V, et al (1998) Urodynamics and transurethral microwave thermotherapy. World J Urol 16:131–137PubMedCrossRef

46.

Osman Y, Wadie B, El-Diasty T, Larson T (2003) High-energy transurethral microwave thermotherapy: symptomatic vs urodynamic success. BJU Int 91:365–370PubMedCrossRef

47.

Kobelt G, Spangberg A, Mattiasson A (2004) The cost of feedback microwave thermotherapy compared with transurethral resection of the prostate for treating benign prostatic hyperplasia. BJU Int 93:543–548PubMedCrossRef

48.

De La Rosette JJ, Floratos DL, Severens JL, Kiemeney LA, Debruyne FM, Pilar Laguna M (2003) Transurethral resection vs microwave thermotherapy of the prostate: a cost-consequences analysis. BJU Int 92:713–718PubMedCrossRef

49.

De Wildt MJ, d’Ancona FC, Hubretgse M, Carter SS, Debruyne FM, de la Rosette JJ (1996) Three-year followup of patients treated with lower energy microwave thermotherapy. J Urol 156:1959–1963PubMedCrossRef

50.

Blute M, Hanson K, Lynch J, et al (1996) United States Prostatron TUMT Study: 4 year follow-up and quality of life. J Urol 155:403A, abstract 370

51.

De la Rosette JM, Desgrandchamp F (1998) Transurethral thermotherapy using the Prostatron device. World J Urol 16:89–95CrossRef

52.

Madersbacher S, Alivizatos G, Nordling J, Sanz CR, Emberton M, de la Rosette JJ (2004) EAU 2004 guidelines on assessment, therapy and follow-up of men with lower urinary tract symptoms suggestive of benign prostatic obstruction (BPH guidelines). Eur Urol 46:547–554PubMedCrossRef

Titel: Transurethral microwave thermotherapy for the treatment of BPH: still a challenger?
verfasst von: T. R. W. Herrmann
A. J. Gross
D. Schultheiss
P. M. Kaufmann
U. Jonas
M. Burchardt
Publikationsdatum: 01.09.2006
Verlag: Springer-Verlag
Erschienen in: World Journal of Urology / Ausgabe 4/2006
Print ISSN: 0724-4983
Elektronische ISSN: 1433-8726
DOI: https://doi.org/10.1007/s00345-006-0098-7

Neu im Fachgebiet Urologie

20.04.2024 | EAU 2024 | Kongressbericht | Nachrichten

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Transurethral microwave thermotherapy for the treatment of BPH: still a challenger?

Abstract

Neu im Fachgebiet Urologie

Harnwegsinfektprophylaxe: Es geht auch ohne Antibiotika

Varikozelen bei Jugendlichen: Das Für und Wider der Operation

Ureterstriktur: Innovative OP-Technik bewährt sich

Prostatakarzinom: EU initiiert neues Screeningkonzept

Update Urologie

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2006

BPH management at the turn of the twenty-first century: evolution or revolution

New approaches in the modulation of bladder smooth muscle cells on viable detrusor constructs

What patients take without telling you: holistic approach for BPH

The evolution of photoselective vaporization prostatectomy (PVP): advancing the surgical treatment of benign prostatic hyperplasia

First-line treatment for symptomatic benign prostatic hyperplasia: is there a particular patient profile for a particular treatment?

Self-management in lower urinary tract symptoms: the next major therapeutic revolution

Neu im Fachgebiet Urologie

Harnwegsinfektprophylaxe: Es geht auch ohne Antibiotika

Varikozelen bei Jugendlichen: Das Für und Wider der Operation

Ureterstriktur: Innovative OP-Technik bewährt sich

Prostatakarzinom: EU initiiert neues Screeningkonzept

Update Urologie